Frequently asked questions

Call (805) 644-3444 or send an inquiry through our contact page. We'll explain how the initial evaluation works and what to bring.

Yes. Reduce was founded in 2014 on physician-supervised weight loss. Prescription treatment is provided only when a licensed provider determines it is appropriate for you.

Call the clinic and we'll let you know what's needed for your situation.

We review your health history and medications, take measurements and talk through your goals and which options are appropriate. See our first-visit guide for what to bring.

No. We never require prepackaged meals. We help you build meals from regular groceries.

No. Non-judgmental care has been part of our approach since day one. Everyone starts somewhere.

Semaglutide is a once-weekly GLP-1 receptor agonist that slows digestion, increases fullness and helps regulate appetite and blood sugar.

Tirzepatide is a once-weekly medication that activates both the GIP and GLP-1 receptors. In clinical trials it produced greater average weight loss than semaglutide.

It depends on your health history, tolerance and goals. Tirzepatide showed larger average weight loss in the SURMOUNT-5 trial, but semaglutide is also highly effective. Your provider will help you choose.

Both semaglutide and tirzepatide are given once a week, ideally on the same day each week.

Starting low and increasing gradually, typically about every four weeks, helps your body adjust and reduces digestive side effects.

Sometimes. Your provider can review your progress and side effects and discuss whether a switch makes sense.

They are not appropriate for people with a personal or family history of medullary thyroid carcinoma or MEN2, and require caution with a history of pancreatitis, gallbladder disease or pregnancy plans. Your evaluation screens for these.

Nausea, constipation, diarrhea, reflux and reduced appetite are most common, usually during dose increases.

Eat smaller meals slowly, stop at the first sign of fullness, limit greasy foods and stay hydrated. Your provider can also slow your dose increases.

Call promptly for severe or persistent abdominal pain, repeated vomiting, signs of dehydration or any symptom that worries you. For emergencies, call 911.

Some lean mass loss happens with any significant weight loss. Eating enough protein and adding resistance exercise helps protect muscle.

Alcohol adds calories, can worsen nausea and affects blood sugar. Discuss your situation with your provider.

Vitamin B12 combined with the lipotropic nutrients methionine, inositol and choline (MIC).

No. It is a nutritional add-on that supports energy metabolism and liver fat processing. It works best as part of an overall plan.

Your provider will recommend a frequency. Established patients can walk in during injection hours.

Yes. Walk-in injection hours are Tuesday 9 AM–1 PM, Wednesday 2–6 PM and Thursday 9 AM–1 PM.

Results vary. In clinical trials, average weight loss was about 15% with semaglutide 2.4 mg over 68 weeks and about 20% with high-dose tirzepatide over 72 weeks. We don't promise specific results.

Many people notice appetite changes within the first weeks. Weight loss usually builds gradually as doses are increased.

Plateaus are normal as your body adapts. Your provider may review your dose, protein intake, activity and sleep. See our plateau pathway.

Exercise isn't required to start, but regular activity — especially strength training — improves results and helps protect muscle.

Studies show many people regain weight after stopping abruptly. A gradual, monitored transition with nutrition support improves your chances of keeping it off.

Not necessarily. Some patients taper off with a maintenance plan; others benefit from longer-term treatment. Your provider will discuss options.

Prioritize protein, vegetables, fruit, whole grains and water. Our nutrition guides cover practical meal structure.

Needs vary by body size and activity. Many people aim for a palm-sized portion at each meal; your provider can personalize a target.

4601 Telephone Rd, Suite 108, Ventura, CA 93003, in the Montalvo corridor near Hwy 101 and Victoria Ave.

Tuesday 9:00 AM–1:00 PM, Wednesday 2:00 PM–6:00 PM and Thursday 9:00 AM–1:00 PM. Closed Monday, Friday, Saturday and Sunday.

Yes. Patients from across Ventura County visit our single Ventura clinic, a short drive via Hwy 101, 33 or 126.

Walk-in injection visits are designed to be quick: check in, a brief check with clinical staff and your injection.

Please call (805) 644-3444 for current parking and arrival details.

Call (805) 644-3444 or email reducemwl@gmail.com.

No. Reduce has never required contracts. You pay as you go.

No. There are no signup fees.

$155 per month for months 1 and 2, $300 per month for months 3 and 4, and $350 per month from month 5 on. Prices increase with dosage as the medication titrates up.

Phentermine, phendimetrazine and diethylpropion hydrochloride are each $140 per month, including provider evaluation and ongoing monitoring.

B-12 injections are $15 each or $50 for a 4-pack ($12.50 per shot). The Super B-12 / Super Diet Shot (B12 + MIC) is $20 each or $70 for a 4-pack ($17.50 per shot).

Tirzepatide starts with an in-person provider consultation. Call (805) 644-3444 for current pricing.

Our programs are pay-as-you-go. Please call the clinic with any insurance questions.

Because there are no contracts, you are not locked in. Talk with your provider before pausing medication so you can do it safely.

Retatrutide is an investigational once-weekly injection that targets three receptors (GLP-1, GIP and glucagon). It is in Phase 3 trials and is not FDA-approved.

No. Retatrutide is not FDA-approved or available. If it is approved, we will evaluate offering it where clinically appropriate.

Approval timing is uncertain. Semaglutide and tirzepatide are well-studied and available today, and progress you make now carries forward.

Retatrutide is not an approved drug, so products sold online are not regulated as approved medications. We advise against using them.